Revenue
2021
2022
2023
2024
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | — | £368.5M | £364.4M | £344.3M | £311.1M |
| Operating expenses | — | £105.6M | £96.2M | £88.2M | £75.3M |
| Operating income | — | £32.8M | £20.8M | £30.6M | £55.6M |
| Operating margin | — | 8.90% | 5.71% | 8.89% | 17.87% |
| EBITDA | — | £45.7M | £30.8M | £37.2M | £60.6M |
| EBITDA margin | — | 12.40% | 8.45% | 10.80% | 19.48% |
| Net income | — | £24.4M | £15.4M | £24.9M | £44.6M |
| Net profit margin | — | 6.62% | 4.23% | 7.23% | 14.34% |
| Basic EPSper basic share | £0.19 | £0.21 | £0.13 | £0.21 | — |
| Diluted EPSper diluted share | £0.19 | £0.21 | £0.13 | £0.21 | — |
Fever-Tree ($FEVR) reported adjusted brand revenue of £183.6 million in the first half, an 8% increase at constant exchange rates. US revenue grew 11% on the same basis as its Molson Coors partnership gained momentum, while the UK returned ...